The head of the scientific council for the national pharmaceutical industries expected a new adjustment to the prices of some basic medicines, whose losses are still significant in economic terms, despite price adjustment in the last bulletin.
Rashid al-Faisal told Melody, a pro-regime radio station, that the medicines will be available in the market within a month, stressing that the shortage was due to high production cost and for reasons beyond the control of the pharmaceutical laboratories related to the black market and monopoly.
The health ministry raised the prices of 11,819 medicinal products last week in response to the warnings of the owners of pharmaceutical factories in Syria, who threatened to stop production if prices were not raised.
The Aliqtisadi-Syria website said the owners of three pharmaceutical factories were not satisfied with the 30% increase in prices, saying the increase should reach 100%, according to the demand of the factories owners in a conference held ten days ago in Damascus.
The owners of pharmaceutical factories assured that the increased rate would not help in providing some of the required pharmaceutical items, due to the high production costs.
The pharmaceutical laboratories confirmed that the required increase rate is similar to the rate of raising the exchange rate against $1 from 1250 to 2512 pounds, or 100%, to be non-losing and at the same time achieve the specified profit rate of 7-9% after deducting taxes and fees.
Syrian medicines exports are currently limited to Iraq, Yemen, Sudan and Libya, due to the economic sanctions.
EQTSAD
Comments About This Article
Please fill the fields below.